cola lipid c efficacy against candida albicans ergosterol disorders as a consequence of the new sulfone derivative action mode | Medicinal Chemistry Research The monoclonal antibody Ca37, developed
The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo Scientific Reports Full article: Synthesis and evaluation of Calenduloside E against drug resistant Candida albicans Targeting Azole Resistant Candida albicans: Tetrapeptide Tuftsin Modified Liposomal Vaccine Induces Superior Immune Protection Candida albicans colonization in the human colon correlates with a reduction in acetate and butyrate producing bacteria, as simulated using the M SHIME model npj Biofilms and Microbiomes Candida albicans accelerates atherosclerosis by activating intestinal hypoxia inducible factor2 signaling ScienceDirect
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




